1. Canadian Cancer Trials Group (CCTG) IND211: A randomized trial of pelareorep (Reolysin) in patients with previously treated advanced or metastatic non-small cell lung cancer receiving standard salvage therapy. (June 2018) Authors: Bradbury, Penelope A.; Morris, Donald G.; Nicholas, Garth; Tu, Dongsheng; Tehfe, Moustapha; Goffin, John R.; Shepherd, Frances A.; Gregg, Richard W.; Rothenstein, Jeffrey; Lee, Christoper; Kuruvilla, Sara; Keith, Bruce D.; Torri, Vamsee; Blais, Normand; Hao, Desiree; Korpanty, Grzegorz J.; Goss, ... Journal: Lung cancer Issue: Volume 120(2018) Page Start: 142 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗